Meanwhile, we noticed that the Ki67 and c-Myc positive cells were severely reduced in the combination group, which further confirmed C504244, in combination with Lenvatinib, exhibits synergistic effects and can reverse Lenvatinib resistance in liver cancer cells. This evidence concerns the gene MYC and liver cancer.